Literature DB >> 26855514

Serological Assessment for Leishmania donovani Infection in Blood Donors of Sunsari District, Dharan, Nepal.

Suraj Timilsina1, Narayan Raj Bhattarai2, Basudha Khanal2, Suman Rijal3.   

Abstract

Visceral leishmaniasis (VL) is a major vector-borne disease caused by Leishmania donovani, after replication of the parasites in macrophages, mononuclear phagocytic system. VL is endemic in 12 districts of central and eastern Terai lowlands of Nepal bordering North Bihar, India with an estimated 8 million population at risk. In addition, VL endemicity is also extending to new endemic regions like Dharan from its classical rural foci. Hence, we aimed to detect the evidence of Leishmania donovani infection in the blood samples received from blood donors of Sunsari district, Dharan, (eastern Nepal), a region endemic for human VL. Sera from 507 asymptomatic blood donors were subjected to serological screening for anti-Leishmania donovani antibodies. Direct agglutination test (DAT) was performed on the sera. Out of 507 donors, majority (78.50 %) were male. Among the donors, 472 (93.10 %) belonged to age group 18-45 years where as 35 (6.90 %) to age group >45 years. Circulating anti-Leishmania antibodies were detected in 5 (1 %) out of 507 healthy, Human Immunodeficiency Virus types 1 and 2 (HIV 1and 2), Hepatitis B Surface Antigen (HBsAg), anti- Hepatitis C Virus (anti-HCV)-negative, and Syphillis non-reactive donors. All the seropositive cases were male and belonged to the age group 18-45 years. The result suggests that there is an immediate need of screening asymptomatic blood donors for leishmania seropositivity especially in endemic areas.

Entities:  

Keywords:  Asymptomatic blood donors; DAT; Dharan; Visceral leishmaniasis

Year:  2015        PMID: 26855514      PMCID: PMC4733681          DOI: 10.1007/s12288-015-0505-6

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  24 in total

1.  Leishmania donovani in blood smears of asymptomatic persons.

Authors:  M C Sharma; A K Gupta; V N Das; N Verma; N Kumar; R Saran; S K Kar
Journal:  Acta Trop       Date:  2000-09-18       Impact factor: 3.112

2.  A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis.

Authors:  Marleen Boelaert; Suman Rijal; Sudhir Regmi; Rupa Singh; Balmansingh Karki; Diane Jacquet; François Chappuis; Lenea Campino; Philippe Desjeux; Dominique Le Ray; Shekhar Koirala; Patrick Van der Stuyft
Journal:  Am J Trop Med Hyg       Date:  2004-01       Impact factor: 2.345

Review 3.  Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Authors:  François Chappuis; Shyam Sundar; Asrat Hailu; Hashim Ghalib; Suman Rijal; Rosanna W Peeling; Jorge Alvar; Marleen Boelaert
Journal:  Nat Rev Microbiol       Date:  2007-11       Impact factor: 60.633

4.  Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal.

Authors:  Suman Rijal; Surendra Uranw; François Chappuis; Albert Picado; Basudha Khanal; Ishwari S Paudel; Elisabeth W Andersen; Filip Meheus; Bart Ostyn; Murari L Das; Clive Davies; Marleen Boelaert
Journal:  Trop Med Int Health       Date:  2010-05-06       Impact factor: 2.622

Review 5.  Transfusion transmitted leishmaniasis: a case report and review of literature.

Authors:  A Dey; S Singh
Journal:  Indian J Med Microbiol       Date:  2006-07       Impact factor: 0.985

6.  The first probable case of platelet transfusion-transmitted visceral leishmaniasis.

Authors:  P Mathur; J C Samantaray
Journal:  Transfus Med       Date:  2004-08       Impact factor: 2.019

7.  Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas?

Authors:  D S Kyriakou; M G Alexandrakis; F H Passam; T V Kourelis; P Foundouli; E Matalliotakis; A N Maniatis
Journal:  Transfus Med       Date:  2003-04       Impact factor: 2.019

8.  Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy.

Authors:  P Guevara; E Rojas; N Gonzalez; J V Scorza; N Añez; M Valera; J L Ramírez
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

9.  Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily.

Authors:  Francesco Scarlata; Fabrizio Vitale; Laura Saporito; Stefano Reale; Valentina Li Vecchi; Salvatore Giordano; Laura Infurnari; Francesco Occhipinti; Lucina Titone
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-03-05       Impact factor: 2.184

10.  Risk factors for kala-azar in Bangladesh.

Authors:  Caryn Bern; Allen W Hightower; Rajib Chowdhury; Mustakim Ali; Josef Amann; Yukiko Wagatsuma; Rashidul Haque; Katie Kurkjian; Louise E Vaz; Moarrita Begum; Tangin Akter; Catherine B Cetre-Sossah; Indu B Ahluwalia; Ellen Dotson; W Evan Secor; Robert F Breiman; James H Maguire
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

View more
  2 in total

Review 1.  Identification of asymptomatic Leishmania infections: a scoping review.

Authors:  Ana Victoria Ibarra-Meneses; Audrey Corbeil; Victoria Wagner; Chukwuemeka Onwuchekwa; Christopher Fernandez-Prada
Journal:  Parasit Vectors       Date:  2022-01-05       Impact factor: 3.876

2.  Leishmania infection in blood donors: A new challenge in leishmaniasis transmission?

Authors:  Adriana de Oliveira França; Mauricio Antonio Pompilio; Elenir Rose Jardim Cury Pontes; Márcia Pereira de Oliveira; Luiza Oliveira Ramos Pereira; Rosimar Baptista Lima; Hiro Goto; Maria Carmen Arroyo Sanchez; Mahyumi Fujimori; Manoel Sebastião da Costa Lima-Júnior; Maria de Fatima Cepa Matos; Maria Elizabeth Moraes Cavalheiros Dorval
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.